Impact of venetoclax dosing on outcomes in AML: A single-center real-world study.
Year: 2026
Type: conference-abstract
Study design: Observational Study
Source: Journal of Clinical Oncology
Institutions: Duke University, Duke Medical Center, Duke Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162679181
Cites:
Cited by:
Related to:
